Cytarabine Improves Combination Therapy for Mantle Cell Lymphoma Clinical Oncology News From the Journal of Clinical Oncology. The addition of cytarabine to bendamustine plus rituximab (R-BAC) as combination therapy for older patients with mantle cell lymphoma (MCL) was found to be both effective and well tolerated. Most patients ... |
